Skip to main content
. 2024 May 8;629(8013):878–885. doi: 10.1038/s41586-024-07385-1

Extended Data Fig. 5. Normalized pseudoviral neutralization of SARS-CoV-2 VOCs by 2130-1-0114-112.

Extended Data Fig. 5

a, f, COV2-2130 and 2130-1-0114-112 potently neutralize WA1/2020 D614G. b, COV2-2130 does not potently neutralize BA.1, whereas 2130-1-0114-112 does, consistent with other pseudoviral neutralization assays. c, 2130-1-0114-112 potently neutralizes BA.2.75, outperforming COV2-2130 by 90-fold. d, e, 2130-1-0114-112 loses substantial potency in the context of BA.4.6 and artificially-produced BA.2.75 + R346T but retains measurable neutralization, demonstrating mitigation of this critical weakness of COV2-2130. g-j, 2130-1-0114-112 maintains weak neutralization of BA.2.75 R346T F486S (g), but loses detectable neutralization activity against BQ.1.1 (h) and XBB (i) and exhibits a near-complete loss of neutralization activity against BN.1 (j). Symbols indicate two independent technical replicates at each concentration. Curves represent a four-parameter logistic curve fit to the data with fixed minimum and maximum values (0 and 100, respectively). k, Neutralization IC50 values in ng/ml. “>” indicates IC50 greater than 10,000 ng/mL. “NC” indicates failure to converge. All analysis conducted in GraphPad Prism.